Literature DB >> 963466

Time course of changes in concentration of some plasma components after frusemide.

T O Haug.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963466      PMCID: PMC1688188          DOI: 10.1136/bmj.2.6036.622

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Factors contributing to intra-individual variation of serum constituents: 4. Effects of posture and tourniquet application on variation of serum constituents in healthy subjects.

Authors:  B E Statland; H Bokelund; P Winkel
Journal:  Clin Chem       Date:  1974-12       Impact factor: 8.327

2.  Factors contributing to intra-individual variation of serum constituents. 2. Effects of exercise and diet on variation of serum constituents in healthy subjects.

Authors:  B E Statland; P Winkel; H Bokelund
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

3.  Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures.

Authors:  S Lal; J G Murtagh; A M Pollock; E Fletcher; P F Binnion
Journal:  Br Heart J       Date:  1969-11

4.  Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration.

Authors:  J Rosenthal; R Boucher; W Nowaczynski; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1968-01       Impact factor: 2.273

  4 in total
  4 in total

1.  Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers.

Authors:  R Lambe; O Kennedy; M Kenny; A Darragh
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 2.  Diuretic therapy and exercise performance.

Authors:  J E Caldwell
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

3.  Hypokalaemia and diuretics: an analysis of publications.

Authors:  D B Morgan; C Davidson
Journal:  Br Med J       Date:  1980-03-29

4.  Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.

Authors:  R Canepa-Anson; J R Dawson; P Kuan; P A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.